Northwest Biotherapeutics | NWBO - Ebit


Northwest Biotherapeutics reported $-13.82M in EBIT for its fiscal quarter ending in September of 2023.





Ebit Change Date
Agenus USD -13.31M 19.08M Mar/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Celldex Therapeutics USD -73.62M 9.76M Sep/2025
Eisai JPY 20.03B 6.36B Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Merck USD 6.24B 1.32B Dec/2025
Northwest Biotherapeutics USD -13.82M 248K Sep/2023
Pfizer USD 4.65B 71M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025